A Kalihinol Analog Disrupts Apicoplast Function and Vesicular Trafficking in Malaria
Authors
Affiliations
We report the discovery of MED6-189, an analog of the kalihinol family of isocyanoterpene natural products that is effective against drug-sensitive and drug-resistant strains, blocking both asexual replication and sexual differentiation. In vivo studies using a humanized mouse model of malaria confirm strong efficacy of the compound in animals with no apparent hemolytic activity or toxicity. Complementary chemical, molecular, and genomics analyses revealed that MED6-189 targets the parasite apicoplast and acts by inhibiting lipid biogenesis and cellular trafficking. Genetic analyses revealed that a mutation in , which encodes a component of the parasite secretory machinery, reduced susceptibility to the drug. Its high potency, excellent therapeutic profile, and distinctive mode of action make MED6-189 an excellent addition to the antimalarial drug pipeline.
Molinski T J Nat Prod. 2024; 88(1):205-210.
PMID: 39704724 PMC: 11773565. DOI: 10.1021/acs.jnatprod.4c01295.
Barnes G, Magann N, Perrotta D, Hormann F, Fernandez S, Vydyam P J Am Chem Soc. 2024; 146(43):29883-29894.
PMID: 39412402 PMC: 11528414. DOI: 10.1021/jacs.4c11897.